blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0006845

EP0006845 - Pharmaceutical composition comprising a 5-aroyl-1-C1-5 alkyl-pyrrole-2-acetic acid compound and acetaminophen or acetylsalicylic acid [Right-click to bookmark this link]
Former [1980/02]Pharmaceutical composition comprising a 5-aroyl-1-lower alkyl-pyrrole-2-acetic acid compound and acetaminophen and/or acetylsalicylic acid
[1982/05]
StatusNo opposition filed within time limit
Status updated on  14.09.2016
Database last updated on 14.09.2024
Most recent event   Tooltip14.09.2016No opposition filed within time limit 
Applicant(s)For all designated states
McNeilab, Inc.
Camp Hill Road Fort Washington
Pennsylvania 19034 / US
[N/P]
Former [1980/02]For all designated states
McNeilab, Inc.
Camp Hill Road
Fort Washington Pennsylvania 19034 / US
Inventor(s)01 / Wong, Stewart
527 Summit Avenue
Fort Washington Pennsylvania / US
[1980/02]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [1980/10]VOSSIUS & PARTNER
Postfach 86 07 67
D-81634 München / DE
Former [1980/02]Vossius, Volker, Dr.
Vossius, Vossius, Hiltl, Tauchner, Heunemann Patentanwälte Siebertstrasse 4
D-8000 München 86 / DE
Application number, filing date78100344.710.07.1978
[1980/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0006845
Date:23.01.1980
Language:EN
[1980/02]
Type: B1 Patent specification 
No.:EP0006845
Date:03.02.1982
Language:EN
[1982/05]
Search report(s)(Supplementary) European search report - dispatched on:EP16.11.1978
ClassificationIPC:A61K31/60, A61K31/40, // (A61K31/60, 31:40),(A61K31/60, 31:40, 31:165)
[1982/05]
CPC:
A61K31/40 (EP); A61K31/60 (EP)
C-Set:
A61K31/40, A61K31/165 (EP);
A61K31/60, A61K2300/00 (EP);
A61K31/60, A61K31/40, A61K31/165 (EP)
Former IPC [1980/02]A61K31/60, // (A61K31/60, 31:40, A61K31/40 ,(A61K31/40, 31:165)
Designated contracting statesBE,   CH,   DE,   FR,   GB,   LU,   NL,   SE [1980/02]
TitleGerman:Ein pharmazeutisches Präparat enthaltend ein Derivat einer 5-Aroyl-1-C1-5 alkyl-pyrrol-2-Essigsäure und Acetaminophen oder Acetylsalicylsäure[1982/05]
English:Pharmaceutical composition comprising a 5-aroyl-1-C1-5 alkyl-pyrrole-2-acetic acid compound and acetaminophen or acetylsalicylic acid[1982/05]
French:Composition pharmaceutique contenant un dérivé d'un acide 5-aroyle-1-alcoyle (C1-5) pyrrole-2-acétique et de l'acétaminophène ou de l'acide acétylsalicylique[1982/05]
Former [1980/02]Ein pharmazeutisches Präparat enthaltend ein Derivat einer 5-Aroyl-1-niedrig alkyl-pyrrol-2-Essigsäure und Acetaminophen und/oder Acetylsalicylsäure
Former [1980/02]Pharmaceutical composition comprising a 5-aroyl-1-lower alkyl-pyrrole-2-acetic acid compound and acetaminophen and/or acetylsalicylic acid
Former [1980/02]Composition pharmaceutique contenant un dérivé d'un acide 5-aroyle-1-alcoyle inférieur-pyrrole-2-acétique et de l'acétaminophène et/ou de l'acide acétylsalicylique
File destroyed:15.01.2000
Examination procedure18.07.1980Examination requested  [1980/21]
06.10.1980Despatch of a communication from the examining division (Time limit: M04)
16.02.1981Reply to a communication from the examining division
30.04.1981Despatch of communication of intention to grant (Approval: )
05.08.1981Communication of intention to grant the patent
29.10.1981Fee for grant paid
29.10.1981Fee for publishing/printing paid
Opposition(s)03.11.1982No opposition filed within time limit [ N /P ]
Fees paidRenewal fee
31.07.1980Renewal fee patent year 03
22.07.1981Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLU31.07.1982
[1999/52]
Documents cited:Search[D]US3752826
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.